Cargando…

The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry

Ferritin is an iron-storage protein and its serum level is known to increase in the patient of with inflammation and malignant tumor. To further elucidate the difference between ferritins from normal human liver tissue and that of cancer cells, their sialic acids were analyzed. The Western blot anal...

Descripción completa

Detalles Bibliográficos
Autores principales: ASAKAWA, Hideo, SASABE, Masataka, MIYAZAKI, Ryuunosuke, MATSUDA, Haruo, FUKAI, Fumio, HANADA, Kazuki, HIRANO, Hisashi, TAKASAKI, Seiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Academy 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323041/
https://www.ncbi.nlm.nih.gov/pubmed/25792781
_version_ 1782356483038511104
author ASAKAWA, Hideo
SASABE, Masataka
MIYAZAKI, Ryuunosuke
MATSUDA, Haruo
FUKAI, Fumio
HANADA, Kazuki
HIRANO, Hisashi
TAKASAKI, Seiichi
author_facet ASAKAWA, Hideo
SASABE, Masataka
MIYAZAKI, Ryuunosuke
MATSUDA, Haruo
FUKAI, Fumio
HANADA, Kazuki
HIRANO, Hisashi
TAKASAKI, Seiichi
author_sort ASAKAWA, Hideo
collection PubMed
description Ferritin is an iron-storage protein and its serum level is known to increase in the patient of with inflammation and malignant tumor. To further elucidate the difference between ferritins from normal human liver tissue and that of cancer cells, their sialic acids were analyzed. The Western blot analysis and the cytochemical staining using anti-NeuGc antiserum indicated that ferritins from the human hepatocarcinoma tissue and malignant K562 cells contain NeuGc, but that from the normal liver does not. The result was also confirmed by HPLC analysis and MALDI-TOF/MS analysis of sialic acids which were derivatized by the DMB method. It was also shown that the sialic acid content in hepatocarcinoma ferritin was much higher than that in the normal liver ferritin. These results suggest that normal and cancerous liver ferritins are qualitatively and quantitatively different in sialylation. In addition, K562 cells were shown to express NeuGc even if the cells were cultured in serum-free media which lack NeuGc. This is of interest from the current concept that expression of NeuGc in human cells is due to uptake and utilization of exogenous NeuGc.
format Online
Article
Text
id pubmed-4323041
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher The Japan Academy
record_format MEDLINE/PubMed
spelling pubmed-43230412015-03-19 The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry ASAKAWA, Hideo SASABE, Masataka MIYAZAKI, Ryuunosuke MATSUDA, Haruo FUKAI, Fumio HANADA, Kazuki HIRANO, Hisashi TAKASAKI, Seiichi Proc Jpn Acad Ser B Phys Biol Sci Articles Ferritin is an iron-storage protein and its serum level is known to increase in the patient of with inflammation and malignant tumor. To further elucidate the difference between ferritins from normal human liver tissue and that of cancer cells, their sialic acids were analyzed. The Western blot analysis and the cytochemical staining using anti-NeuGc antiserum indicated that ferritins from the human hepatocarcinoma tissue and malignant K562 cells contain NeuGc, but that from the normal liver does not. The result was also confirmed by HPLC analysis and MALDI-TOF/MS analysis of sialic acids which were derivatized by the DMB method. It was also shown that the sialic acid content in hepatocarcinoma ferritin was much higher than that in the normal liver ferritin. These results suggest that normal and cancerous liver ferritins are qualitatively and quantitatively different in sialylation. In addition, K562 cells were shown to express NeuGc even if the cells were cultured in serum-free media which lack NeuGc. This is of interest from the current concept that expression of NeuGc in human cells is due to uptake and utilization of exogenous NeuGc. The Japan Academy 2006-07 /pmc/articles/PMC4323041/ /pubmed/25792781 Text en © 2006 The Japan Academy This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
ASAKAWA, Hideo
SASABE, Masataka
MIYAZAKI, Ryuunosuke
MATSUDA, Haruo
FUKAI, Fumio
HANADA, Kazuki
HIRANO, Hisashi
TAKASAKI, Seiichi
The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry
title The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry
title_full The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry
title_fullStr The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry
title_full_unstemmed The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry
title_short The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry
title_sort analysis of n-glycolylneuraminic acid(neugc) of hepatoma tissue and k562 cell ferritins using hplc and mass spectrometry
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323041/
https://www.ncbi.nlm.nih.gov/pubmed/25792781
work_keys_str_mv AT asakawahideo theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT sasabemasataka theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT miyazakiryuunosuke theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT matsudaharuo theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT fukaifumio theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT hanadakazuki theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT hiranohisashi theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT takasakiseiichi theanalysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT asakawahideo analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT sasabemasataka analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT miyazakiryuunosuke analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT matsudaharuo analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT fukaifumio analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT hanadakazuki analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT hiranohisashi analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry
AT takasakiseiichi analysisofnglycolylneuraminicacidneugcofhepatomatissueandk562cellferritinsusinghplcandmassspectrometry